JihadGeorgesYoussefMD

Pulmonology • Houston, TX

Critical Care Medicine, Interventional Pulmonology, Pleural Disease

Greater Houston Lung And Sleep Center

Join to view full profile

Dr. Youssef is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Youssef's full profile

Already have an account?

Office
6560 Fannin St
Ste 1234
Houston, TX 77030
Phone+1 832-834-5346

Fax+1 832-834-5347

Education & Training

UPMC Medical EducationFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2003
Stony Brook Medicine/University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2002
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1996 - 1999
American University of Beirut Faculty of MedicineClass of 1995

Certifications & Licensure

AZ State Medical License 2002 - 2026
TX State Medical License 2012 - 2026
LA State Medical License 2020 - 2022
OK State Medical License 2002 - 2020
MD State Medical License 2000 - 2005
PA State Medical License 2002 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine

Clinical Trials

Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure Start of enrollment: 2020 May 15
Completed
Phase 2, Phase 3
ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)
No longer available

Publications & Presentations

PubMed

4 citations
Pneumatocele and cysts in a patient with severe acute respiratory syndrome coronavirus 2 infection.
Nishal Brahmbhatt, Omar Tamimi, Henry Ellison, Sai Katta, J.G. Youssef
JTCVS Techniques. 2020-08-21
11 citations
The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.
Jihad Georges Youssef, Philip Lavin, David A Schoenfeld, Richard A Lee, Rainer Lenhardt
Critical Care Medicine. 2022-11-01
13 citations
G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?
J.G. Youssef, F. Zahiruddin, George Youssef, Sriram Padmanabhan, Joe Ensor
Annals of Hematology. 2021-01-01

Press Mentions

Clinical Trials and Research News Weekly Roundup | USAMRDC Develops COVID-19 Vaccine Candidate SpFNOctober 26th, 2020
RLF-100 Expanded Access Program at Houston Methodist Hospital 9-Fold Increased Probability of Survival from Critical COVID-19October 15th, 2020